Trial intelligence / Profile preview

Finasteride for hospitalized older men with COVID-19 pneumonia

IRCT20200505047318N1Phase 3Completed

Sponsor
Qazvin University of Medical Sciences
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of finasteride in coronavirus pneumonia (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: oxygen saturation, disease period and 1 more. Started Mar 2020; status: completed.

02

Drugs

finasteride
03

Conditions

coronavirus pneumonia

Beyond the preview

Go deeper on IRCT20200505047318N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200505047318N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call